SARS-CoV-2 Spike-derived Peptide (NGVEGFNCYFPLQSY)
Antibody screening, T-cell assays, Immune monitoring, Antigen specific T-cell stimulation, Cellular immune response
RP30234 | |
|
|
$160.00 | |
|
|
|
|
Ask us a question |
RP30234 | |
|
|
$160.00 | |
|
|
|
|
Ask us a question |
Description | Antibody screening, T-cell assays, Immune monitoring, Antigen specific T-cell stimulation, Cellular immune response |
Sequence |
{Asn}{Gly}{Val}{Glu}{Gly}{Phe}{Asn}{Cys}{Tyr}{Phe}{Pro}{Leu} {Gln}{Ser}{Tyr} |
Sequence Shortening | NGVEGFNCYFPLQSY |
Molecular Weight | 1737.89 |
Purity | >95% |
Solubility | Can be dissolved in DMSO |
Form | Lyophilized |
Storage | Store at -20°C. Keep tightly closed. Store in a cool dry place. |
For laboratory research use only. Direct human use, including taking orally and injection and clinical use are forbidden.